Tue, Dec 23, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Preqin finds 80% of alternative investors plans to maintain or increase their allocations

Monday, May 27, 2013

Beverly Chandler, Opalesque London: The latest survey from Preqin finds that investors are proactive and committed to alternative assets with at least 80% of investors in each alternative asset class plan to maintain or increase their allocations throughout 2013 and 50% proactive in sourcing investment opportunities.

The 2013 Preqin Investor Network Global Alternatives Report is designed to help investors navigate alternative asset Markets, and this year it demonstrated that investors have confidence in a wide range of alternatives including private equity, hedge funds, real estate and infrastructure. The firm says: "Furthermore, a significant proportion of investors recently surveyed by Preqin indicates they proactively source alternative asset fund investments , and do so using dedicated investment employees, indicating they are becoming increasingly interested in managing and developing their alternative assets portfolios."

Highlights from the report include:

  • Half of investors surveyed by Preqin in April 2013 has a proactive approach to sourcing alternative asset fund investments, with a further 31% adopting a mixture of proactive and passive approaches.
  • 64% of investors has an internal investment team that proactively sources and examines alternative asset fund investments.
  • Two - thirds (67%) have two or more investment - focused employees dedicated to alternative assets .......................

    To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Investing - Big hedge funds win again on PetSmart, Riverbed, RBS sells real estate loans to hedge fund Cerberus, Talisman energy speculation: Which hedge funds could benefit?[more]

    Big hedge funds win again on PetSmart, Riverbed From CNBC.com: Another week, another set of wins for activist investors. On Sunday, pet supply retailer PetSmart agreed to the largest leveraged buyout of the year at $8.7 billion. Hedge fund firm JANA Partners had been pushing for a sale a

  2. Outlook - Hedge fund manager who remembers 1998 rout says prepare for pain, Bond guru Bill Gross predicts U.S. economic growth to dip to 2%[more]

    Hedge fund manager who remembers 1998 rout says prepare for pain From Bloomberg.com: Stephen Jen landed in Hong Kong in early January 1997 as Morgan Stanley’s newly minted exchange-rate strategist for Asia. He was soon working around the clock when investors began targeting the region’s

  3. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  4. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  5. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for